HOLX Research and Charts

HOLX - Hologic Inc (Healthcare: Medical Instruments & Supplies)

Projected Earnings Date: 2025-07-31 (Delayed quote data 2025-06-30)

Last 65.16	Change ⇑ +0.15 (+0.23%)	Volume 1,590,544
	Open 64.94	High 65.39	Low 64.76

8EMA (Daily) 64.77	40EMA (Daily) 62.30	50EMA (Daily) 62.05	STO (Daily) 58.715	MACD Hist (Daily) -0.179
8EMA (Weekly) 62.989	40EMA (Weekly) 66.19	50EMA (Weekly) 67.41	STO (Weekly) 87.763	MACD Hist (Weekly) 2.646


Company Profile
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: breast health (44% of sales), diagnostics (39%) surgical (14%), and skeletal health (3%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (74%), followed by Europe (12%), Asia (9%), and other international markets (5%). Hologic is headquartered in Bedford, Massachusetts.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.